Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1(IIIB) GP120 peptide RP135

被引:90
作者
Huang, XL
Barchi, JJ
Lung, EDT
Roller, PP
Nara, PL
Muschik, J
Garrity, RR
机构
[1] NCI, MED CHEM LAB, DIV BASIC SCI, BETHESDA, MD 20892 USA
[2] NCI, VACCINE RESISTANT DIS SECT, DIV BASIC SCI, FREDERICK CANC RES & DEV CTR, FREDERICK, MD 21702 USA
关键词
D O I
10.1021/bi9703655
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have prepared glycosylated analogues of the principal neutralizing determinant of gp120 and studied their conformations by NMR and circular dichroism spectroscopies. The 24-residue peptide from the HIV-1(IIIB) isolate (residues 308-331) designated RP135, which contains the immunodominant tip of the V3 loop, was glycosylated with both N- and O-linked sugars. The structures of two glycopeptides, one with an N-linked beta-glucosamine (RP135(NG)) and. the other with two O-linked alpha-galactosamine units (RP135(digal)), were studied by NMR and circular dichroism spectroscopies. Molecular dynamics calculations based on the NMR data obtained in water solutions were performed to explore the conformational substates sampled by the glycopeptides. The data showed that covalently linking a carbohydrate to the peptide has a major effect on the local conformation and imparts additional minor changes at more distant sites of partially defined secondary structure. In particular, the transient beta-type turn comprised of the -Gly-Pro-Gly-Arg- segment at the ''tip'' of the V3 loop is more highly populated in RP135(digal) than in the native peptide and N-linked analogue. Binding data for the glycopeptides with 0.5 beta, a monoclonal antibody mapped to the RP135 sequence, revealed a significant enhancement in binding for RP135(digal) as compared with the native peptide, whereas binding was reduced for the N-linked glycopeptide. These data show that glycosylation of V3 loop peptides can affect their conformations as well as their interactions with antibodies, The design of more ordered and biologically relevant conformations of immunogenic regions from gp120 may aid in the design of more effective immunogens for HIV-1 vaccine development.
引用
收藏
页码:10846 / 10856
页数:11
相关论文
共 72 条
[61]   CHEMICAL GLYCOSYLATION OF PEPTIDE T AT NATURAL AND ARTIFICIAL GLYCOSYLATION SITES STABILIZES OR REARRANGES THE DOMINANT REVERSE TURN STRUCTURE [J].
URGE, L ;
GORBICS, L ;
OTVOS, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (02) :1125-1132
[62]   HIGH-RESOLUTION, H-1-NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY AS A TOOL IN THE STRUCTURAL-ANALYSIS OF CARBOHYDRATES RELATED TO GLYCOPROTEINS [J].
VLIEGENTHART, JFG ;
DORLAND, L ;
VANHALBEEK, H .
ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, 1983, 41 :209-374
[63]   Conformational features of a synthetic cyclic peptide corresponding to the complete V3 loop of the RF HIV-1 strain in water and water/trifluoroethanol solutions [J].
Vranken, WF ;
Budesinsky, M ;
Martins, JC ;
Fant, F ;
Boulez, K ;
GrasMasse, H ;
Borremans, FAM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (01) :100-108
[64]   Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CANOA based on solution NMR: Comparison to a related immunogenic peptide from HIV-1 RF [J].
Vu, HM ;
deLorimier, R ;
Moody, MA ;
Haynes, BF ;
Spicer, LD .
BIOCHEMISTRY, 1996, 35 (16) :5158-5165
[65]   Piperidine is preferred to morpholine for Fmoc cleavage in solid phase glycopeptide synthesis as exemplified by preparation of glycopeptides related to HIV gp120 and mucins [J].
Vuljanic, T ;
Bergquist, KE ;
Clausen, H ;
Roy, S ;
Kihlberg, J .
TETRAHEDRON, 1996, 52 (23) :7983-8000
[66]   BROADLY NEUTRALIZING MONOCLONAL-ANTIBODIES TO THE V3-REGION OF HIV-1 CAN BE ELICITED BY PEPTIDE IMMUNIZATION [J].
WHITESCHARF, ME ;
POTTS, BJ ;
SMITH, LM ;
SOKOLOWSKI, KA ;
RUSCHE, JR ;
SILVER, S .
VIROLOGY, 1993, 192 (01) :197-206
[67]   THE CHEMICAL-SHIFT INDEX - A FAST AND SIMPLE METHOD FOR THE ASSIGNMENT OF PROTEIN SECONDARY STRUCTURE THROUGH NMR-SPECTROSCOPY [J].
WISHART, DS ;
SYKES, BD ;
RICHARDS, FM .
BIOCHEMISTRY, 1992, 31 (06) :1647-1651
[68]  
WOODY RW, 1995, METHOD ENZYMOL, V246, P34
[69]  
Wuthrich K., 1986, EUROPHYS NEWS, V17, P11
[70]   SOLUTION CONFORMATION OF A PEPTIDE CORRESPONDING TO THE PRINCIPAL NEUTRALIZING DETERMINANT OF HIV-1(IIIB) - A 2-DIMENSIONAL NMR-STUDY [J].
ZVI, A ;
HILLER, R ;
ANGLISTER, J .
BIOCHEMISTRY, 1992, 31 (30) :6972-6979